Preferential Cancer Cell Self-Recognition and Tumor Self-Targeting by Coating Nanoparticles with Homotypic Cancer Cell Membranes

The ultimate goal in cancer therapy and diagnosis is to achieve highly specific targeting to cancer cells. Coated with the source cancer cell membrane specifically derived from the homologous tumors, the nanoparticles are identified with the self-recognition internalization by the source cancer cell...

Full description

Saved in:
Bibliographic Details
Published in:Nano letters 2016-09, Vol.16 (9), p.5895-5901
Main Authors: Zhu, Jing-Yi, Zheng, Di-Wei, Zhang, Ming-Kang, Yu, Wu-Yang, Qiu, Wen-Xiu, Hu, Jing-Jing, Feng, Jun, Zhang, Xian-Zheng
Format: Article
Language:English
Subjects:
Animals
Cell Line, Tumor
Cell Membrane - chemistry
Doxorubicin - administration & dosage
Doxorubicin - chemistry
Drug Delivery Systems
Ferric Compounds - chemistry
Humans
Magnetic Resonance Imaging
Magnetics
Mice
Nanoparticles
Neoplasms - drug therapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The ultimate goal in cancer therapy and diagnosis is to achieve highly specific targeting to cancer cells. Coated with the source cancer cell membrane specifically derived from the homologous tumors, the nanoparticles are identified with the self-recognition internalization by the source cancer cell lines in vitro and the highly tumor-selective targeting “homing” to the homologous tumor in vivo even in the competition of another heterologous tumor. As the result, MNP@DOX@CCCM nanovehicle showed strong potency for tumor treatment in vivo and the MR imaging. This bioinspired strategy shows great potential for precise therapy/diagnosis of various tumors merely by adjusting the cell membrane source accordingly on the nanoparticle surface.
ISSN:1530-6984
1530-6992
DOI:10.1021/acs.nanolett.6b02786